Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Neurocrine Biosciences
Biotech
J&J innovator vaults to Valo—Chutes & Ladders
J&J innovator vaults to Valo. Alterome snags expert dealmaker as CEO. Newleos and the seven new execs.
Darren Incorvaia
,
Zoey Becker
Apr 11, 2025 8:30am
Harbour spinoff pens $395M deal for preclinical Crenessity rival
Feb 26, 2025 5:14am
Takeda taps Julie Kim as new CEO—Chutes & Ladders
Jan 31, 2025 8:30am
Takeda regains home rights to depression drug from Neurocrine
Jan 28, 2025 4:16am
Neurocrine, Idorsia part ways 2 years after double phase 2 fails
Oct 29, 2024 7:15am
Neurocrine's bid to save schizophrenia prospect fails
Sep 13, 2024 7:30am
